PSYCHOGENICS INC.
Doing business as PSYCHOGENICS INC
- PARAMUS, NJ 07652-1400
- psychogenics.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
PSYCHOGENICS INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About PSYCHOGENICS INC.
- Headquarters
- PARAMUS, NJ 07652-1400
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIYXMNA8N7LFG4
- CAGE8HHD9
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 24 awards
- Total awarded
- $14,097,788
- By phase
- SBIR Phase I: 20
- SBIR Phase II: 3
- STTR Phase I: 1
- By agency
- Department of Health and Human Services: 24
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 1
- 2024: 1
- 2023: 1
- 2019: 1
- 2014: 1
- 2012: 1
- 2011: 1
- 2008: 4
- 2007: 4
- 2006: 1
- 2005: 1
- 2004: 2
- 2003: 3
- 2002: 2
Awards (most recent first)
Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $495,699
Sep 20, 2025 – Sep 19, 2026
Solicitation PAS22-196 (2022) · Topic NIA
EEG Signature Analysis for Drug Repurposing for Rare Diseases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,020,875
Aug 5, 2024 – Jul 31, 2026
Solicitation PA23-230 (2023) · Topic 101
Machine Learning Phenotypic De Novo Drug Design
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $999,892
Aug 15, 2023 – Jul 31, 2025
Solicitation PA22-176 (2022) · Topic 101
Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $538,405
Jul 12, 2019 – Jul 11, 2020
Solicitation PA18-591 (2018) · Topic 101
Predictive Smoking Cessation Preclinical Battery
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,607,051
Sep 30, 2014 – Jul 31, 2016
Solicitation PA12-088 (2013) · Topic R44
Predictive Smoking Cessation Preclinical Battery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $829,176
Solicitation PA12-088 (2012) · Topic NIDA · Research partner: Stub
Eltoprazine for the Treatment of Cognitive Dysfunction Assoc. With Schizophrenia
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $700,000
Solicitation PA08-142 (2011) · Topic NIMH · Research partner: Stub
HDAC6-Selective Inhibitors for Pancreatic Cancer Treatment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $366,682
Solicitation PHS2007-2 (2008)
Prodrugs of NAAG Peptidase Inhibitors for the Treatment of Schizophrenia
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $620,426
Solicitation PHS2007-2 (2008)
NAAG Peptidase Inhibitors for the Treatment of Traumatic Brain Injury
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $760,811
Solicitation PHS2007-2 (2008)
High Throughput in Vivo Drug Discovery - Phase II
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2008 · $1,350,000
Solicitation PHS2007-2 (2008)
Nicotinic Ligands as Smoking Cessation Agents
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $288,900
Solicitation year 2007 · Research partner: UNVERSITY OF MISSISSIPPI MEDIC
High Throughput Behavioral Testing For Novel Antidepressants
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $250,000
Solicitation year 2007
Piperidine-Based Compounds as Therapeutics for Narcolepsy-Cataplexy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $250,000
Solicitation year 2007
Development of GSK-3 Beta Inhibitors for the Treatment of Parkinson's Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $282,568
Solicitation year 2007
Higher Throughput Behavioral Screening of Cognitive
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $399,963
Solicitation PHS2006-2 (2006)
In Vivo Drug Discovery From Compound Mixtures
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $468,176
Solicitation PHS2005-2 (2005)
HIGH THROUGHPUT IN VIVO DRUG DISCOVERY-PHASE 1
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $500,000
Solicitation PHS2004-2 (2004)
Animal Models of Schizophrenia: NRG-erbB Function
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $500,000
Solicitation PHS2004-2 (2004)
Wolframin gene ablation in mice as a model for human men
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $448,546
Spinal Cord Injury: Automatic Scoring of Motor Function
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $234,554
Highthroughput analysis of behavior for CNS applications
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2003 · $934,490
DEVELOPMENT OF AMYGDALA SPECIFIC MONOCLONAL ANTIBODIES
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $123,906
HIGHTHROUGHPUT ANALYSIS OF BEHAVIOR FOR CNS APPLICATIONS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $127,668
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with PSYCHOGENICS INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
